Efficacy Study of Acupuncture to Treat the Upper Abdominal Pain of Cancer Patients
NCT ID: NCT01913574
Last Updated: 2021-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2013-03-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupuncture & NCPB
The NCPB will be administered once at the start of the trial and the acupuncture will be performed 3 times per week for 2 weeks (6 times in total).
Acupuncture
Acupuncture is applied three times a week for 20 minutes for 2 weeks (total 6 sessions). 9 Acupuncture points, CV12, CV13, P6, SP4, ST36(bilateral),LI4 (bilateral), LR3 (bilateral), ST34 (bilateral), and GB21(bilateral) are used, and CV12, CV13, ST36, and LR3 are electro-stimulated.
Neurolytic celiac plexus block (NCPB)
An anaesthetic test is performed injecting 2ml mepivacaine. After assessing the efficacy and safety of this test, 10 ml of absolute alcohol is injected via each needle.
NCPB
The NCPB alone will be applied to the patients in this group, once at the start of the trial.
Neurolytic celiac plexus block (NCPB)
An anaesthetic test is performed injecting 2ml mepivacaine. After assessing the efficacy and safety of this test, 10 ml of absolute alcohol is injected via each needle.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupuncture
Acupuncture is applied three times a week for 20 minutes for 2 weeks (total 6 sessions). 9 Acupuncture points, CV12, CV13, P6, SP4, ST36(bilateral),LI4 (bilateral), LR3 (bilateral), ST34 (bilateral), and GB21(bilateral) are used, and CV12, CV13, ST36, and LR3 are electro-stimulated.
Neurolytic celiac plexus block (NCPB)
An anaesthetic test is performed injecting 2ml mepivacaine. After assessing the efficacy and safety of this test, 10 ml of absolute alcohol is injected via each needle.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Upper abdominal pain VAS ≥ 5
* Unresectable abdominal malignancy, moderate or severe abdominal pain poorly controlled with pharmacotherapy.
* All patients had advanced cancer diagnosed by histological/cytological examination
* Follow-up possible during the clinical trial
* Written informed consent voluntarily
Exclusion Criteria
* Patient with allergy to local anesthesics or alcohol..
* Previous NCPB or had implanted epidural or intrathecal analgesic therapy
* Inability to lie prone
* Disease encasing the celiac plexus on computed Tomography scan
* Patients with psychiatric diseases that could have affected the study assessments
* Significant renal or hepatic disease
* Inability to comprehend or express oneself in the Korean language
* Refusal to participate in the trial or to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Daegu Catholic University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jin Yong Jung
Department of anesthesiolgy
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeong-Chul Seo, KMD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Comprehensive and Integrative Medicine Institute
Min-Ah Gwak, KMD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Daegu Oriental Hospital of Daegu Haany University
Seong_Hoon Park, KMD
Role: PRINCIPAL_INVESTIGATOR
Comprehensive and Integrative Medicine Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Daegu Catholic University Medical Center
Daegu, Kyungsangbukdo, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIMI-13-01-09
Identifier Type: -
Identifier Source: org_study_id